Full-Time

Maintenance Fitter

Confirmed live in the last 24 hours

Viatris

Viatris

10,001+ employees

Compensation Overview

$50/hr

+ Performance Cycle + Overtime

Junior, Mid

Brisbane QLD, Australia

Category
Mechanical Maintenance and Reliability Engineering
Mechanical Engineering
Requirements
  • Ability to diagnose and resolve mechanical issues quickly and efficiently.
  • Precision in work to ensure machinery is maintained to the highest standards.
  • Ability to spot small issues before they turn into larger problems.
  • Strong collaboration with other maintenance staff, engineers, and production teams.
  • Ability to prioritise tasks to ensure timely completion of maintenance tasks with minimal disruption to production.
  • A commitment to adhering to safety protocols and ensuring the work environment is hazard-free.
  • Ability to train and mentor others on safety procedures.
  • Proficiency in reading and interpreting technical drawings and manuals.
  • Knowledge of the latest technology and best practices in maintenance and mechanical repairs.
  • A proactive approach to maintaining equipment before issues arise to avoid costly downtime.
  • The ability to maintain good client relations and service efficiency.
Responsibilities
  • Ensure all work is carried out in a professional manner to the highest standard.
  • Follow and apply company policies and objectives, SOPs, GMP and health and safety requirements whilst completing duties.
  • Champion safety across the site, identify hazards and provide engineering solutions where required.

Company Size

10,001+

Company Stage

IPO

Headquarters

Canonsburg, Pennsylvania

Founded

1961

Simplify Jobs

Simplify's Take

What believers are saying

  • Viatris benefits from the rise of value-based healthcare models, aligning with patient outcomes.
  • Expansion in emerging markets offers Viatris opportunities to reach underserved populations.
  • Focus on digital health solutions could expand Viatris' service offerings significantly.

What critics are saying

  • Increased competition from biosimilars threatens Viatris' market share in key areas.
  • Ongoing patent expirations lead to revenue declines as generics enter the market.
  • Fluctuating foreign exchange rates pose financial risks to Viatris' global revenue streams.

What makes Viatris unique

  • Viatris bridges the gap between generics and brands, offering a unique healthcare approach.
  • The company has a strong global presence, enhancing its market reach and influence.
  • Viatris' diverse portfolio includes innovative licensing agreements, like with Lexicon Pharmaceuticals.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Life Insurance

401(k) Retirement Plan

401(k) Company Match

Wellness Program

Paid Holidays

Company News

PR Newswire
Mar 28th, 2025
Viatris To Report First Quarter 2025 Financial Results On May 8, 2025

PITTSBURGH, March 28, 2025 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) will report first quarter 2025 financial results on Thursday, May 8, 2025. Company executives will host a webcast at 8:30 a.m. ET on the same date to discuss the results.Investors and the general public are invited to listen to a live webcast of the call at investor.viatris.com or by calling 844.308.3344 or 412.317.1896 for international callers. A replay of the webcast also will be available on the website.About ViatrisViatris Inc. (NASDAQ: VTRS) is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally

PR Newswire
Mar 5th, 2025
Viatris To Present At The Barclays 27Th Annual Global Healthcare Conference

PITTSBURGH, March 5, 2025 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS), a global healthcare company, will present at the Barclays 27th Annual Global Healthcare Conference in Miami Beach, FL on Tuesday, March 11, 2025. The company's fireside chat will begin at 2 p.m. ET.A live webcast of the event at can be found at investor.viatris.com. An archived version of the presentation will be available following the live event and can be accessed at the same location for a limited time.About ViatrisViatris Inc. (NASDAQ: VTRS) is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally

PR Newswire
Feb 27th, 2025
Viatris Maintains Dividend Policy For 2025 And Announces Quarterly Dividend

PITTSBURGH, Feb. 27, 2025 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) today announced that on February 24, 2025, its Board of Directors approved a 2025 dividend policy of 48 cents ($0.48) per share and declared a quarterly dividend of 12 cents ($0.12) for each issued and outstanding share of the Company's common stock. The dividend is payable on March 18, 2025, to shareholders of record at the close of business on March 10, 2025. This marks the fifth consecutive year the Company has paid a dividend.About ViatrisViatris Inc. (NASDAQ: VTRS) is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally

PR Newswire
Feb 3rd, 2025
Viatris To Report Fourth Quarter And Full Year 2024 Financial Results On February 27, 2025

PITTSBURGH, Feb. 3, 2025 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) will report financial results for the fourth quarter and full year 2024 on Thursday, February 27, 2025. Company executives will host a webcast at 8:30 a.m. ET on the same date to discuss the results.Investors and the general public are invited to listen to a live webcast of the call at investor.viatris.com or by calling 844.308.3344 or 412.317.1896 for international callers. A replay of the webcast also will be available on the website.About ViatrisViatris Inc